NCT03031730 2026-02-10
Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
National Cancer Institute (NCI)
Phase 1 Terminated
Clinical Trials
4 trialsNCT05350163 2024-12-10
T-cell Receptor α/β Depleted Donor Lymphocyte Infusion
Baptist Health South Florida
Phase 1 Terminated
NCT03312868 2022-04-06
Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma
Instituto do Cancer do Estado de São Paulo
Phase 2 Terminated
NCT00109889 2017-04-24
S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma
SWOG Cancer Research Network
Phase 2 Terminated